nach oben

Erschienen in:

01.04.2012

Nine years of Experience with the Sentinel Lymph Node Biopsy in a Single Italian Center: A Retrospective Analysis of 1,050 Cases

verfasst von: Sergio Bernardi, Serena Bertozzi, Ambrogio P. Londero, Francesco Giacomuzzi, Vito Angione, Cinzia Dri, Arnalda Carbone, Roberto Petri

Erschienen in: World Journal of Surgery | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

This study aims to determine the prevalence and predictive factors for recurrence after sentinel lymph node biopsy (SLNB) and for sentinel lymph node positivity by SLNB in our population.

Methods

We followed up all SLNBs performed between 2002 and 2010 and analyzed data by R (version2.10.1), considering p < 0.05 significant.

Results

Among 1,050 patients with SLNB, 23% (245/1050) underwent secondary axillary dissection (CALND). Axillary recurrence prevalence among patients with negative SLNB was 1% (6/805) at a mean follow-up of 54 months (±14), and 1.7% (95% CI 0.2–3.1%) after 6 years of follow-up, as all recurrences developed between the 3rd and the 6th years of follow-up. By multivariate analysis, axillary recurrence results correlated with large tumor size, high number of excised nodes, lymphovascular invasion, high grading, multifocality, Her-2 positivity, intraductal histology, and comedo-like necrosis. Moreover, SLNB positivity results correlated with young age, large tumor size, high number of excised nodes, negative history for second primary malignancies, lymphovascular invasion, and high grading.

Conclusions

Cancer characteristics represent important predictive factors for SLNB positivity, as well as for axillary recurrence in patients with negative SLNB, independently, by surgical and nonsurgical treatment. Therefore, cancer biological behavior and the patient’s hormonal profile should be evaluated with care to better tailor the follow-up of women with breast cancer.

Nur mit Berechtigung zugänglich

Rescigno J, Zampell JC, Axelrod D (2009) Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol 16:687–696PubMedCrossRef

Johnson MT, Guidroz JA, Smith BJ et al (2009) A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients. Surgery 146:671–676 discussion 676–677PubMedCrossRef

Dauphine C, Nemtsev D, Rosing D et al (2010) Axillary recurrence after sentinel lymph node biopsy for breast cancer. Am Surg 76:1127–1129PubMed

Cyr A, Gillanders WE, Aft RL et al (2010) Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden. Ann Surg Oncol 17(Suppl 3):303–311PubMedCrossRef

Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933PubMedCrossRef

Giuliano AE, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426–432 discussion 432–433PubMed

Iannace C, Libero LD, Lepore M et al (2010) Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience. Ann Ital Chir 81:103–111 discussion 112–113PubMed

Degnim AC, Zakaria S, Boughey JC et al (2010) Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)]. Ann Surg Oncol 17:2685–2689PubMedCrossRef

Kim HJ, Son BH, Lim WS et al (2010) Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up. Ann Surg Oncol 17:2126–2131PubMedCrossRef

10.

Sampol C, Giménez M, Torrecabota J et al (2010) Axillary recurrences after sentinel lymph node biopsy in initial breast cancer. Rev Esp Med Nucl 29:241–245PubMedCrossRef

11.

Sanli I, Lemaire BMD, Muller AJ et al (2009) Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term. Breast J 15:236–241PubMedCrossRef

12.

Kiluk J, Ly Q, Meade T et al (2009) Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Ann Surg Oncol 17:552–557CrossRef

13.

Heuts EM, van der Ent FWC, Hulsewé KWE et al (2008) Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients. Acta Chir Belg 108:203–207PubMed

14.

Palesty JA, Foster JM, Hurd TC et al (2006) Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. J Surg Oncol 93:129–132PubMedCrossRef

15.

Torrenga H, Fabry H, van der Sijp JRM (2004) Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. J Surg Oncol 88:4–7 discussion 7–8PubMedCrossRef

16.

Bilimoria KY, Bentrem DJ, Hansen NM et al (2009) Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27:2946–2953PubMedCrossRef

17.

Langer I, Guller U, Hsu-Schmitz SF et al (2009) Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 35:805–813PubMedCrossRef

18.

Canavese G, Catturich A, Vecchio C et al (2009) Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann Oncol 20:1001–1007PubMedCrossRef

19.

Veronesi U, Galimberti V, Paganelli G et al (2009) Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 45:1381–1388PubMedCrossRef

20.

Sun JY, Ning LS (2008) Axillary skip metastases in breast cancer. Zhonghua Zhong Liu Za Zhi 30:352–355PubMed

21.

Kim HJ, Son BH, Park EW et al (2009) Axillary recurrence after negative sentinel lymph node biopsy. Breast Cancer Res Treat 114:301–305PubMedCrossRef

22.

Murray KL, Lambah PA, Anderson TJ et al (2002) Occult lymph node metastases in patients with “node negative” breast carcinoma treated with conservation surgery and axillary node sample and who subsequently developed axillary recurrence. Breast 11:249–251PubMedCrossRef

23.

Schneebaum S, Stadler J, Cohen M et al (1998) Gamma probe-guided sentinel node biopsy—optimal timing for injection. Eur J Surg Oncol 24:515–519PubMedCrossRef

24.

Borgstein PJ, Pijpers R, Comans EF et al (1999) Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275–283CrossRef

25.

Verkooijen HM, Chatelain V, Fioretta G et al (2007) Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat 105:347–357PubMedCrossRef

26.

Gauthier T, Mollard J, Fermeaux V et al (2009) Axillary recurrence after negative sentinel lymph node biopsy under local anesthesia in breast cancer. Eur J Surg Oncol 35:464–468PubMedCrossRef

27.

Mustac E, An-Ilijaâ KM, Marijic B et al (2009) Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy. Int J Surg Pathol 18:36–41PubMedCrossRef

28.

Chen JJ, Huang XY, Liu ZB et al (2009) Sentinel node biopsy and quality of life measures in a Chinese population. Eur J Surg Oncol 35:921–927PubMedCrossRef

29.

Helms G, Kühn T, Moser L et al (2009) Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection—data from a prospective randomised trial. Eur J Surg Oncol 35:696–701PubMedCrossRef

30.

Natarajan S, Taneja C, Cady B (2005) Evolution of lymphadenectomy in surgical oncology. Surg Oncol Clin N Am 14:447–459PubMedCrossRef

31.

Winchester DP, Trabanino L, Lopez MJ (2005) The evolution of surgery for breast cancer. Surg Oncol Clin N Am 14:479–498PubMedCrossRef

32.

Takács T, Paszt A, Szentpáli K et al (2008) Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer. Pathol Oncol Res 15:329–333CrossRef

33.

Gurleyik G, Gurleyik E, Aker F et al (2007) Lymphovascular invasion, as a prognostic marker in patients with invasive breast cancer. Acta Chir Belg 107:284–287PubMed

34.

Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421PubMedCrossRef

35.

Cote R, Giuliano AE, Hawes D et al. (2010) ACOSOG Z0010: a multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. J Clin Oncol (Meeting Abstracts) 28(18S):CRA504

36.

Pazaiti A, Fentiman IS (2011) Which patients need an axillary clearance after sentinel node biopsy? Int J Breast Cancer 2011 Article ID 195892

37.

Tjan-Heijnen VC, Pepels MJ, de Boer M et al (2009) Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0[i+]) in the sentinel lymph node (SN): results from the MIRROR study. ASCO Meeting Abstracts 27(18S):CRA506

38.

Leidenius M, Vironen J, Heikkilä P et al (2009) Influence of isolated tumor cells in xentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol 17:252–262

39.

Meretoja TJ, Leidenius MH, Heikkilä PS et al (2009) Sentinel node biopsy in breast cancer patients with large or multifocal tumors. Ann Surg Oncol 16:1148–1155PubMedCrossRef

40.

Ejlertsen B, Jensen MB, Rank F et al (2009) Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 101:729–735PubMedCrossRef

41.

Yagata H, Harigaya K, Suzuki M et al (2003) Comedonecrosis is an unfavorable marker in node-negative invasive breast carcinoma. Pathol Int 53:501–506PubMedCrossRef

42.

Bézu C, Coutant C, Antoine M et al (2009) Feasibility of the sentinel node biopsy in breast cancer in case of histological multifocality diagnosis. Gynecol Obstet Fertil 37:604–610PubMedCrossRef

43.

Veronesi U, Orecchia R, Zurrida S et al (2005) Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 16:383–388PubMedCrossRef

44.

Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. J Am Med Assoc 305:569–575CrossRef

45.

Pandit TS, Kennette W, Mackenzie L et al (2009) Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment. Int J Oncol 35:297–308PubMed

46.

Oliveira LR, Jeffrey SS, Ribeiro-Silva A (2010) Stem cells in human breast cancer. Histol Histopathol 25:371–385PubMed

47.

Colpaert C, Vermeulen P, Jeuris W et al (2001) Early distant relapse in “node-negative” breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 193:442–449PubMedCrossRef

Titel: Nine years of Experience with the Sentinel Lymph Node Biopsy in a Single Italian Center: A Retrospective Analysis of 1,050 Cases
verfasst von: Sergio Bernardi
Serena Bertozzi
Ambrogio P. Londero
Francesco Giacomuzzi
Vito Angione
Cinzia Dri
Arnalda Carbone
Roberto Petri
Publikationsdatum: 01.04.2012
Verlag: Springer-Verlag
Erschienen in: World Journal of Surgery / Ausgabe 4/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-011-1420-0

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Is It Possible to Train Surgeons for Rural Africa? Reply

Early Data from the First Population-Wide Breast Cancer-Specific Registry in Hong Kong

Pilot Testing of a Population-based Surgical Survey Tool in Sierra Leone

Utility of Drain Fluid Amylase Measurement on the First Postoperative Day after Pancreaticoduodenectomy

Laparoscopic Appendectomy in Pregnant Women: Experience in Chittagong, Bangladesh

Modification of the Trauma and Injury Severity Score (TRISS) Method Provides Better Survival Prediction in Asian Blunt Trauma Victims

Update Chirurgie